Longitudinal quantification of serum SARS-CoV-2 neutralising antibodies, pro-inflammatory cytokines, NfL and GFAP before and after breakthrough COVID-19 infection in CNS neuroimmunological diseases: a prospective observational study.

Saved in:
Bibliographic Details
Title: Longitudinal quantification of serum SARS-CoV-2 neutralising antibodies, pro-inflammatory cytokines, NfL and GFAP before and after breakthrough COVID-19 infection in CNS neuroimmunological diseases: a prospective observational study.
Authors: Hema Prashaad M; Duke-NUS Medical School, Singapore, Singapore., Siew RWE; Department of Neurology (Tan Tock Seng Hospital Campus), National Neuroscience Institute, Singapore, Singapore., Aw AYY; Department of Neurology (Tan Tock Seng Hospital Campus), National Neuroscience Institute, Singapore, Singapore., Hui Yi Tan J; National Neuroscience Research Laboratories, National Neuroscience Institute, Singapore, Singapore., Gulam Mohamed MY; Department of Neurology (Singapore General Hospital Campus), National Neuroscience Institute, Singapore, Singapore., Siew Noi JT; Department of Neurology (Tan Tock Seng Hospital Campus), National Neuroscience Institute, Singapore, Singapore., Prasad K; Department of Neurology (Tan Tock Seng Hospital Campus), National Neuroscience Institute, Singapore, Singapore., Tan K; Duke-NUS Medical School, Singapore, Singapore.; Department of Neurology (Tan Tock Seng Hospital Campus), National Neuroscience Institute, Singapore, Singapore., Kuhle J; Neuroimmunology Unit and Multiple Sclerosis Centre, University Hospital Basel, Basel, Switzerland., Chao Y; Duke-NUS Medical School, Singapore, Singapore.; Department of Neurology (Singapore General Hospital Campus), National Neuroscience Institute, Singapore, Singapore., Ho IA; Duke-NUS Medical School, Singapore, Singapore.; National Neuroscience Research Laboratories, National Neuroscience Institute, Singapore, Singapore., Yeo T; Department of Neurology (Tan Tock Seng Hospital Campus), National Neuroscience Institute, 11 Jalan Tan Tock Seng, Level 3, Clinical Staff Office, Singapore 308433, Singapore.; Duke-NUS Medical School, Singapore, Singapore.; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
Source: Therapeutic advances in infectious disease [Ther Adv Infect Dis] 2025 Sep 09; Vol. 12, pp. 20499361251370471. Date of Electronic Publication: 2025 Sep 09 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: SAGE Publications Country of Publication: England NLM ID: 101606715 Publication Model: eCollection Cited Medium: Print ISSN: 2049-9361 (Print) Linking ISSN: 20499361 NLM ISO Abbreviation: Ther Adv Infect Dis Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2049-9361
DOI:10.1177/20499361251370471